New <i>N</i>-(3′-acetyl-8-nitro-2,3-dihydro-1<i>H</i>,3′<i>H</i>-spiro[quinoline-4,2′-[1,3,4]thiadiazol]-5′-yl) acetamides induced cell death in MCF-7 cells <i>via</i> G2/M phase cell cycle arrest
作者:Selvaraj Shyamsivappan、Raju Vivek、Thangaraj Suresh、Palanivel Naveen、Adhigaman Kaviyarasu、Sundarasamy Amsaveni、Shunmuganarayanan Athimoolam、Palathurai Subramaniam Mohan
DOI:10.1039/d1nj02550c
日期:——
cells. The compounds showed superior inhibitory action towards MCF-7 malignant growth cells. Amongst the twelve compounds investigated, compound 4a showed significant inhibitory activity, and the cell death mechanism was evaluated by fluorescent staining, and flow cytometry analyses. The in vitro anticancer results revealed that compound 4a induced cell death by G2/M phase cell cycle arrest. The binding
一系列新型N- (3′-乙酰基-8-nitro-2,3-dihydro-1 H , 3′H-螺[quinoline-4,2′-[1,3,4]thiadiazol]-5′ -yl) 乙酰胺衍生物由有效的 8-硝基喹啉-氨基硫脲合成。通过不同的光谱研究和单 X 射线晶体学研究对合成的化合物进行了表征。评估了这些化合物对 MCF-7 和 HeLa 细胞的体外抗癌特性。这些化合物对MCF-7恶性生长细胞显示出优异的抑制作用。在研究的十二种化合物中,化合物4a显示出显着的抑制活性,并通过荧光染色和流式细胞仪分析评估了细胞死亡机制。体外的抗癌结果显示,化合物4a通过 G2/M 期细胞周期停滞诱导细胞死亡。分子对接研究证实了化合物与 ERα 的结合亲和力及其药代动力学特性。